These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 15285526)

  • 1. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.
    Cagnola H; Scaravonati R; Cabanne A; Bianchi C; Gruz F; Errea A; Zambernardi A; Meier D; Chirdo F; Docena G; Gondolesi G; Rumbo M
    Transplant Proc; 2010; 42(1):57-61. PubMed ID: 20172281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
    Joshi S; Lewis SJ; Creanor S; Ayling RM
    Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin in very low birth weight infants.
    Josefsson S; Bunn SK; Domellöf M
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):407-13. PubMed ID: 17414135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?
    Baldassarre ME; Fanelli M; Lasorella ML; Laneve A; Grosso R; Falcone MR; Laforgia N
    Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):220-3. PubMed ID: 20602542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR; Lyon TD; Duncan A; Neilly JB; Han S; Howell J; Liddell C; Stanley AJ; Morris AJ; Mackenzie JF
    QJM; 2005 Jun; 98(6):435-41. PubMed ID: 15879440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
    Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
    Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pediatrics. Fecal calprotectin in children: use and interpretation].
    Ezri J; Nydegger A
    Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin concentration in children affected by SIBO.
    Fundarò C; Fantacci C; Ansuini V; Giorgio V; Filoni S; Barbaro F; Gasbarrini A; Rossi C
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1328-35. PubMed ID: 22195368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.